Print Page

Other safety alerts

 
Taiwan: Announcement on matter related to update of Chinese package insert of oral medicinal products containing Ginkgo biloba extract
 
In Hong Kong, there are four registered oral pharmaceutical products containing ginkgo biloba extract, ginkgo biloba or ginkgo biloba leaf. So far, the Department of Health (DH) has not received any adverse drug reaction case on the products containing the said ingredients. In view of the announcement of the Taiwan FDA, letters to healthcare professionals will be issued to draw their attention to the warning, and the matter will be discussed in the meeting of the Registration Committee of the Pharmacy and Poisons Board.

Please refer to the following Chinese website for details: http://www.drugoffice.gov.hk/eps/news/../25112.html

Ends/ Friday, September 04, 2015
Issued at HKT 16:00
 
 
back